|
CHEK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.124500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.533800E-02 |
| Normal-vs-Stage2 |
5.652200E-01 |
| Normal-vs-Stage3 |
3.393700E-02 |
| Normal-vs-Stage4 |
3.863200E-01 |
| Stage1-vs-Stage2 |
2.868200E-01 |
| Stage1-vs-Stage3 |
5.265800E-01 |
| Stage1-vs-Stage4 |
4.124000E-01 |
| Stage2-vs-Stage3 |
1.812850E-01 |
| Stage2-vs-Stage4 |
8.249200E-01 |
| Stage3-vs-Stage4 |
2.448200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.465800E-02 |
| Normal-vs-AfricanAmerican |
1.028240E-02 |
| Normal-vs-Asian |
3.074200E-01 |
| Caucasian-vs-AfricanAmerican |
6.995700E-02 |
| Caucasian-vs-Asian |
3.776400E-01 |
| AfricanAmerican-vs-Asian |
7.829700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.598410E-01 |
| Normal-vs-Female |
5.188100E-02 |
| Male-vs-Female |
6.053000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.075700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.164200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.045600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.506400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.654300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.114000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.475400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.451000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.025200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.198200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.288600E-01 |
| Classical-VS-Follicular |
9.116300E-02 |
| Classical-VS-Other |
6.632800E-01 |
| Classical-VS-Normal |
2.569900E-02 |
| Tall-VS-Follicular |
1.449030E-01 |
| Tall-VS-Other |
5.206600E-01 |
| Tall-VS-Normal |
5.607900E-02 |
| Follicular-VS-Other |
9.020000E-01 |
| Follicular-VS-Normal |
4.951600E-01 |
| Other-VS-Normal |
6.388800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.042300E-02 |
| Normal-vs-N1 |
2.315800E-01 |
| N0-vs-N1 |
4.967600E-01 |
|
|
